The body’s immune system runs on a circadian rhythm, meaning the timing of treatments like immunotherapy or vaccines can influence how well they work. Studies in humans and animals show that morning administration often leads to stronger immune responses and better survival outcomes, a finding now being explored for canine cancer care.

Learn more about Elias Cancer Immunotherapy (ECI), a newly USDA-approved treatment for dogs with osteosarcoma. It explains how ECI works, its benefits, success rates, costs, and availability for families seeking new options in canine cancer care.

Dr. Jeffrey Bryan of the University of Missouri explains how the Elias Cancer Immunotherapy works, what the response rates look like, and the types of canine cancers it may treat. He also addresses eligibility, access, and potential side effects.

EGFR vaccine helped Dennis overcome osteosarcoma without losing his leg.

List of new immunotherapy treatments for dogs with osteosarcoma. Immunotherapy treatments may give dogs a chance for longer remission and survival, compared to standard therapies alone (e.g. surgery plus chemotherapy)

New treatment options for hemangiosarcoma.

Immunocidin may be a gentler alternative to chemotherapy, according to Max's mom.

Prof Mark Mamula (Yale School of Medicine) joined us for a webinar, during which he shared updates about the EGFR/HER2 Canine Cancer...

When I first learned about a new cancer vaccine that might reduce the risk for many aggressive canine cancers, I wanted to sign up our...